Loading...

Castle Biosciences, Inc.

CSTL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$24.46
$0.77(3.25%)
U.S. Market opens in 23h 4m

Castle Biosciences, Inc. (CSTL) Stock Overview

Explore Castle Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap727.2M
P/E Ratio-29.72
EPS (TTM)$-0.83
ROE-0.05%
Fundamental Analysis

AI Price Forecasts

1 Month$24.75
3 Months$33.03
1 Year Target$32.95

CSTL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Castle Biosciences, Inc. (CSTL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.54, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -29.72 and a market capitalization of 727.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.25%
5-Day Change
-2.70%
1-Month Change
-3.51%
3-Month Change
-42.09%
6-Month Change
-0.20%
Year-to-Date (YTD) Change
-37.12%
1-Year Change
16.87%
3-Year Change
2.95%
5-Year Change
-65.18%
All-Time (Max) Change
14.30%

Contact Information

https://castlebiosciences.com
866 788 9007
505 South Friendswood Drive, Friendswood, TX, 77546

Company Facts

784 Employees
IPO DateJul 25, 2019
CountryUS
Actively Trading

Frequently Asked Questions